Company profile: Fluorogenics
1.1 - Company Overview
Company description
- Provider of cutting-edge sample-to-result integrated analyzers and real-time PCR lyophilized reagents, bringing technical expertise to these solutions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fluorogenics
InVitro International
HQ: United States
Website
- Description: Provider of proprietary non-animal testing alternatives, with a pioneering focus on their development and application.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InVitro International company profile →
Q Chip
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical drug delivery, developing a range of sustained-release biogeneric and biotherapies products (Q-Sphera).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q Chip company profile →
Dualsystems Biotech
HQ: Switzerland
Website
- Description: Provider of proteomic services for industry and academia, offering mass spectrometry-based proteomics and ligand-receptor interaction platforms: LRC-TriCEPS to identify interactions on living cells for drug discovery and receptor identification, and HATRIC-LRC to find receptors for orphan ligands. Swiss biotech founded in 2000 with yeast two-hybrid technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dualsystems Biotech company profile →
Zedira
HQ: Germany
Website
- Description: Provider of transglutaminase-focused biotech solutions, including specialty reagents for R&D and diagnostics; small-molecule drug candidates such as ZED1227 for celiac disease; fee-for-service transglutaminase activity measurement; recombinant microbial transglutaminase (Andracon) for ADC production; diagnostic antigens (TG2, TG3, TG6, DGPs); and an Anti-TG6 ELISA kit.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zedira company profile →
Dewpoint Therapeutics
HQ: United States
Website
- Description: Provider of condensate-modifying drugs and an AI-powered drug discovery platform focused on biomolecular condensates. Offers therapies targeting TDP-43 for ALS and neurodegenerative diseases and beta catenin for cancers such as colorectal cancer. Engages in partnerships with pharmaceutical companies to develop drugs for cardiovascular diseases, insulin resistance, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dewpoint Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fluorogenics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fluorogenics
2.2 - Growth funds investing in similar companies to Fluorogenics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fluorogenics
4.2 - Public trading comparable groups for Fluorogenics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →